 - Impairment of gastrointestinal GI function or GI disease that may significantly alter the absorption of PTK787ZK222584 e.g., ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, bowel obstruction, or inability to swallow the capsulestablets 